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MicroRNA Detection by DNA-Mediated Liposome Fusion
Coline Jumeaux,[a] Olov Wahlsten,[b] Stephan Block,[b, d] Eunjung Kim,[a] Rona Chandrawati,[a, c]
Philip D. Howes,[a] Fredrik Hççk,*[b] and Molly M. Stevens*[a]
Membrane fusion is a process of fundamental importance in
biological systems that involves highly selective recognition
mechanisms for the trafficking of molecular and ionic cargos.
Mimicking natural membrane fusion mechanisms for the pur-
pose of biosensor development holds great potential for am-
plified detection because relatively few highly discriminating
targets lead to fusion and an accompanied engagement of a
large payload of signal-generating molecules. In this work, se-
quence-specific DNA-mediated liposome fusion is used for the
highly selective detection of microRNA. The detection of miR-
29a, a known flu biomarker, is demonstrated down to 18 nm
within 30 min with high specificity by using a standard labora-
tory microplate reader. Furthermore, one order of magnitude
improvement in the limit of detection is demonstrated by
using a novel imaging technique combined with an intensity
fluctuation analysis, which is coined two-color fluorescence
correlation microscopy.
The detection of target molecules in a specific and sensitive
manner is of critical importance for the development of effi-
cient disease diagnostic devices. Nature is a great source of in-
spiration for the design of such platforms because throughout
the course of evolution highly sensitive and specific sensing or
signaling processes have emerged that use refined compo-
nents made of only a few molecular building blocks.[1] One of
these mechanisms is the fusion of lipid bilayers; an essential
process that allows the transfer of chemicals through an other-
wise impervious barrier,[2, 3] which facilitates inter- and intracel-
lular communication.[4] In the case of neuronal fusion, in which
Ca2+-triggered neurotransmitter release into the synaptic cleft
from a vesicle occurs on the sub-millisecond timescale,[5] com-
plex molecular machinery facilitates this highly regulated pro-
cess, and proteins belonging to the SNARE family (soluble N-
ethylmaleimide-sensitive factor attachment protein receptors)
have emerged as the key components to facilitate the molecu-
lar recognition and fusion of bilayers.[6–8]
An increased understanding of biological processes and the
design principles underlying recognition enables the progres-
sion of the field of the design of biomimetic materials, which
harness the power and efficiency of natural processes, com-
bined with biological building blocks (e.g. , DNA, RNA, pep-
tides, proteins, lipids) to create hierarchically organized materi-
als, and the development of a new generation of sensors.[1]
Membrane fusion has been extensively studied by using
model systems, such as proteoliposomes, in which native fuso-
genic proteins are exposed on the surface of artificial lipid vesi-
cles (liposomes).[9–14] Another approach involves the design of
biologically inspired constructs to trigger liposome docking
and membrane fusion. Simplified synthetic analogues are an
excellent tool to increase the understanding of the fusion pro-
cess at the atomistic level, and each segment of the synthetic
construct can be varied to study its role in the occurrence of
fusion.[2] Synthetic analogues enabling specific molecular rec-
ognition used to trigger membrane fusion include coiled-coil
forming peptides[3,15] and DNA.[16–19] Cholesterol-terminated
double-stranded DNA (dsDNA) has been shown to facilitate ef-
ficient self-insertion into liposomes,[20] and that their hybridiza-
tion, if designed to occur in a zipper-like fashion, can induce
liposome–liposome fusion (Figure S1 in the Supporting Infor-
mation).[18,19] DNA, thanks to its high selectivity in sequence-
guided self-assembly, has great potential for biosensing appli-
cations. Attractive properties of liposomes, such as ease of
functionalization and biocompatibility, endow them with
promising applications in biomedical and biotechnology
fields.[21–23] Furthermore, with relatively few targets leading to
fusion and engagement of a large payload of signaling mole-
cules (e.g. , FRET-active dyes), it is reasonable to assume that
target-mediated liposome fusion could lead to highly amplified
detection. Inspired by this reasoning, we have engineered a
sensing platform for detecting a clinically relevant biomarker
for influenza virus infection,[24] microRNA-29a (miR-29a), in a
highly specific and sensitive manner by DNA-mediated lipo-
some membrane fusion. This work, conjointly with a recent
report demonstrating the possibility of triggering peptide nu-
cleic acid mediated liposome fusion with oligonucleotides,[25]
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constitutes the first example of biomarker-triggered liposome
fusion.
Herein, we encapsulated FRET donor–acceptor pairs, DiI and
DiD (Figure S2), in the membrane of DNA-functionalized lipo-
somes. In this assay, liposomes containing either DiI or DiD
FRET pairs in the membrane are functionalized with self-insert-
ing, cholesterol-terminated dsDNA (Figure 1). A hairpin DNA
(H, green strand in Figure 1) is designed to block the sticky
end of dsDNA A/B (ds-A/B), which prevents hybridization with
dsDNA C/D (ds-C/D) and inhibits liposome docking and fusion.
The hairpin DNA is also specially designed to include a region
containing a complementary sequence with miR-29a. Hence, in
the presence of target miRNA, hybridization with hairpin DNA
reveals the sticky end of ds-A/B, which can then hybridize with
ds-C/D to initialize liposome docking and membrane fusion.
This is then detected by an increase in FRET signal. The report-
ed liposome fusion mechanism for oligonucleotide detection
presents several key advantages in its experimental design. It
is a homogeneous assay, operated at room temperature, and
involving relatively few experimental steps. Notably, other lipo-
some-based assays for oligonucleotide detection require the
destruction of liposomes through the addition of membrane-
disrupting agents.[21,26] Herein, similarly to assays developed by
Jakobsen et al. ,[27,28] the readout is obtained without the need
for additional separation, amplification, and washing steps,
which has great potential for further developing this assay to-
wards point-of-care applications.
In this assay, schematically illustrated in Figure 1, the hairpin
DNA strand (H) is designed to hybridize on the sticky end of a
duplex and to be displaced in the presence of target miRNA.
This novel mechanism of a dual-function hairpin DNA is an ad-
vantageous strategy because it offers a unique site for target
hybridization, which is independent of the zippering regions;
therefore, its design is universal and can be tailored to adapt
to a broad spectrum of target biomarkers. It is crucial to opti-
mize the design of H to meet the following three require-
ments: 1) unbound H must maintain its structural stem-loop
feature (not a random coil structure), and have at least one
arm of the stem that is part of the recognition sequences; 2) H
must be strongly hybridized to ds-A/B in the absence of
target, which prevents the hybridization of A with C and fur-
ther unzipping of the dsDNAs; and 3) H must be displaced
only by the specific target miRNA (T), revealing the sticky end
of ds-A/B, which will initiate liposome docking by hybridization
with ds-C/D.
We designed three hairpin structures: H6, H7, and H13 (se-
quences in Table S1). The optimization of the hairpin design is
summarized in section S5 (Supporting Information). Briefly,
first, we visualized the predicted secondary structures formed
by the hybridization of H, A, and B (Figure S3) by using algo-
rithms provided in the NUPACK software,[29] which also showed
that out of the three predicted constructs, ds-A/B/H7 had the
highest probability of formation (Table S2). Furthermore, the
hybridization and displacement of H in solution were charac-
terized by means of native PAGE analysis (Figure S4). We dem-
onstrated that only H7 showed both efficient hybridization
with ds-A/B and displacement by T; therefore, H7 was chosen
as the hairpin structure for the liposome fusion assay.
Following selection of H7, we translated the hairpin strand
displacement mechanism in the presence of target miR-29a
into a liposome fusion assay. The majority of methods for de-
tecting membrane fusion are based on fluorescence genera-
tion or FRET, and careful choice of the reporter assay allows se-
lective discrimination between lipid mixing (inner or outer lipid
leaflet) and content mixing.[30] To maximize signal generation
during the assay, we selected a lipid-mixing assay to report
Figure 1. Schematic illustration for the process of miRNA detection based on the promotion of DNA-mediated liposome fusion. Target miRNA (red strand)
is complementary to the hairpin (green strand) and hybridizes to it ; this displacement reveals the sticky end of ds-A/B. In the presence of target miRNA,
liposome fusion is promoted by ds-A/B and ds-C/D hybridizing in a zipper-like manner, which results in an increase in FRET signal. In the absence of target
miRNA, liposome fusion is inhibited because hairpin DNA remains hybridized on ds-A/B and no FRET increase is observed.
ChemBioChem 2018, 19, 434 – 438 www.chembiochem.org T 2018 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim435
Communications
fusion events because studies have shown that a high level of
lipid mixing can occur with a limited degree of content
mixing.[17] DiI and DiD FRET pairs are based on Cy3 and Cy5
cyanine dyes, respectively (Figure S2), and contain long alkyl
chains that render them highly lipophilic ; therefore, they will
be included in the membrane of liposomes. Two populations
of liposomes containing either DiI or DiD were mixed; upon
membrane fusion, these fluorescent dyes mixed, resulting in
FRET signal generation.
DiD and DiI liposomes were functionalized with ds-A/B/H7
and ds-C/D, respectively, and we studied the ability of miR-29a
to displace H7 and trigger liposome fusion (Figure 2). DiD lipo-
somes were incubated with various quantities of miR-29a.
Then, equal volumes of DiI and DiD liposomes were mixed and
the evolution of the FRET ratio was measured over time (Fig-
ures 2A and S5). In the absence of miR-29a, the FRET ratio
slightly increased during the first 20 min of measurement then
plateaued, which showed that H7 was successfully hybridized
on ds-A/B and was able to prevent liposome fusion. As the
quantity of miR-29a increased, the FRET ratio and its gradient
in the first 20 min increased; this demonstrated that miR-29a
was able to displace H7 and trigger liposome fusion. To study
the sensitivity of the assay, we plotted the dose–response
curve obtained after 30 min of incubating DiI and DiD lipo-
somes (Figure 2B). The limit of detection (LOD) was calculated
by first determining the z value (z=blank+3s), in which s is
the standard deviation of the blank. The LOD was determined
to be 18 nm by reporting the z value in the equation of the
curve fitted to the dose–response measurements.
Next, the specificity of the assay was studied (Figure 3). The
miR-29 family members are important regulators of human
diseases,[31] and include miR-29a, miR-29b-1, miR-29b-2, and
miR-29c. In a microarray assay, the expression levels of both
miR-29a and miR-29b were significantly different between criti-
cally ill patients with H1N1 infection and healthy controls.[24]
We tested the ability of the assay to discriminate between the
fully complementary target, miR-29a, and its miR-29 family
counterparts, miR-29b and miR-29c. The sequences of miR-29b
and miR-29c differ from that of miR-29a by several mismatch-
ing and additional nucleotides (Table S1). Therefore, to study
the specificity of our assay, we designed artificial sequences,
differing from miR-29a by 1, 2, or 3 nucleotides: miR-29a-1MM,
miR-29a-2MM, and miR-29a-3MM (Table S1). DiD liposomes
functionalized with ds-A/B/H7 were incubated with one molar
equivalent of different miRNAs. Subsequently, equal volumes
of DiI and DiD liposomes were mixed, and the evolution of the
FRET signal was measured over time (Figures 3A and S6). Only
the fully complementary target, miR-29a, was able to trigger
liposome fusion, whereas no other sequences showed a signifi-
cant increase in the FRET ratio, relative to that of the signal
measured in the absence of target. Figure 3B summarizes the
relative values of the FRET ratios at 30 min of incubation ob-
tained with each miRNA, relative to the control, and showed
that our assay had a high specificity because we were able to
discriminate between sequences with one nucleotide mis-
match.
This high specificity is attributed to the fact that displacing
the hairpin requires high stringency.[32] Although the LOD
Figure 2. Evaluation of the sensitivity of the DNA-mediated liposome fusion
assay for miR-29a detection: A) Evolution of the FRET signals over time
showing the kinetics of DNA-mediated liposome fusion in the presence of
different concentrations of target miR-29a (1 T corresponds to 2.1V10@7m),
and B) corresponding dose–response curve obtained after 30 min of mixing
DiI- and DiD-labeled DNA-functionalized liposomes (n=3). Error bars repre-
sent standard deviation.
Figure 3. Evaluation of the specificity of the DNA-mediated liposome fusion
assay for miR-29a detection: A) Evolution of the FRET signals over time
showing the kinetics of DNA-mediated liposome fusion in the presence of
various miRNA sequences at a concentration of 2.1V10@7m. B) Correspond-
ing bar chart representing the FRET ratio values relative to the control for
each miRNA sequence 30 min after mixing DiI- and DiD-labeled DNA-func-
tionalized liposomes. n=3, *p<0.05 (ANOVA followed by Tukey post-hoc
test). Error bars represent standard deviation.
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value reported herein is much higher than that obtained with
other miRNA detection methods based on enzymatic target
amplification,[33,34] this assay remarkably distinguished strong
sequence homologies, which is typically difficult to achieve for
homogeneous assays that do not incorporate washing, amplifi-
cation, or separation steps.[35] Additionally, the DNA-mediated
liposome fusion assay reduces the complexity and risk of
errors that would otherwise be associated with enzymatic
target amplification.[36]
To further the understanding of the assay for miRNA detec-
tion and potentially gain in detection limit and/or minimize
material consumption, a suspension-based two-color fluores-
cence correlation microscopy method was developed that
allowed extraction of FRET signals from imaging low numbers
of liposomes (<50).[37] The experimental setup is presented in
section S7 (Supporting Information). In brief, it comprises a
regular fluorescence microscope equipped with a beam splitter
(Figure S7a), which enables the simultaneous separation of the
emitted light originating from DiI liposomes (centered around
l=570 nm; denoted as the “green channel” in the following)
and fused DiI and DiD liposome complexes (centered around
l=670 nm; “red channel”) upon direct excitation of DiI lipo-
somes by a laser source (l=488 nm).
We exploited the increased sensitivity in terms of liposome
concentration of the two-color fluorescence microscopy setup
and mixed liposome solutions at 10 pm concentration for incu-
bation with the target, and then diluted the solutions to 1 pm
before performing the measurements (compared with 1.7 nm
liposome concentration used for the microplate reader setup).
Due to its large conceptual similarity to that of fluorescence
correlation spectroscopy (FCS),[38–40] we tried to assess FRET
characteristics from the intensity fluctuations of Ig(t) and Ir(t)
(intensity traces integrated over the entire green and red chan-
nels, respectively). In FCS, the average number, N, of fluores-
cent particles within the readout volume (usually a diffraction-
limited spot due to the usage of a confocal excitation scheme)
can be obtained by calculating the autocorrelation function, g,
of the recorded fluorescence intensity trace, I(t) [Eq. (1)] ,
gðtÞ ¼ hIðtÞ ? Iðt þ tÞihIðtÞi2 @ 1 ð1Þ
and by employing N=1/g(0).[41] As shown in section S7 (Sup-
porting Information), the same methodology can be applied to
the intensity traces obtained from our microscope setup, if the
autocorrelation function of the intensity ratio Ir(t)/Ig(t) is calcu-
lated. This normalization was necessary because fluctuations in
Ir(t) were caused by two processes, fused FRETing liposomes
and bleed-through of DiI liposomes, making g(0) more sensi-
tive to the number of DiI liposomes than that of fused FRETing
DiD liposomes (section S7). Because DiI liposomes cause corre-
lated fluctuations in Ig(t) and Ir(t), the use of Ir(t)/Ig(t) eliminates
the sensitivity of DiI liposomes, but boosts FRET-based fluctua-
tions (Figure 4A), making g(0) mainly sensitive to the number
of fused FRETing DiD liposomes (section S7 and Figure S8).
Representative examples for the autocorrelation function of
Ir(t)/Ig(t) are shown in Figure 4B, clearly indicating a decrease in
g(0) with increasing miR-29a concentration, which is, due to
N&1/g(0), indicative of an increase in the number of fused
FRETing DiD liposomes, NFRET, in the field of view. Calibration of
this approach with solutions containing only FRETing vesicles
of known bulk concentration, cFRET (Figure S9), allowed us to
extract a dose–response curve (Figure 4C) similar to that of
the microplate reader assay. The LOD obtained with the two-
color fluorescence correlation microscopy setup was deter-
mined to be 1.2 nm, which was a one order of magnitude
improvement in sensitivity compared with that of ensemble
measurements obtained by using the microplate reader setup.
Hence, two-color fluorescence correlation microscopy has in its
current implementation an improved performance relative to
that of the microplate reader assay (in terms of LOD), and con-
sumes three orders of magnitude less material thanks to its
ability to operate at liposome concentrations as low as 1 pm
(in contrast to 1.7 nm used in the microplate reader assay).
In summary, we set out to explore whether DNA-mediated
liposome fusion could be controlled by interactions with spe-
cific nucleic acid targets, and whether this mechanism could
form the basis of a detection assay. We successfully demon-
Figure 4. A) The Ir(t)/Ig(t) ratio of the total intensity of the red channel over
the green channel. B) Representative autocorrelation functions of Ir(t)/Ig(t)@g
(with g=0.065 as the average bleed-through factor), for miR-29a concentra-
tions indicated (1 T corresponds to 7.2V10@10m). C) Dose–response curve
obtained by using the two-color fluorescence correlation microscopy setup
(averaged over three independent sample sets, covering at least five meas-
urements each). Error bars represent SEM. See Section S7 in the Supporting
Information for details of the entire process.
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strated sensitive and specific detection of miR-29a at nanomo-
lar concentrations by using a FRET-based fluorescence output,
and explored two methods of analyzing the fluorescence
signal. With a standard laboratory microplate reader, a LOD of
18 nm was obtained, whereas, with two-color fluorescence
correlation microscopy combined with an intensity fluctuation
analysis, we observed a LOD improved by one order of magni-
tude. Liposome and analyte concentrations that were three
orders of magnitude lower than those used in the microplate
reader assay were employed, and demonstrated the utility of
such a setup in both the study of liposome fusion and applica-
tion in a biosensing system. Furthermore, our system has po-
tential in the development of new diagnostic platforms target-
ing miRNA and other nucleic acids. By optimizing the highly
promising concept of relatively few targets leading to fusion
and activation of a large payload of signal-generating mole-
cules, the LOD could be much improved in subsequent itera-
tions. Factors such as assay temperature, dsDNA coverage, and
choice of reporter signal are expected to improve the sensitivi-
ty in our assay, and will be the subject of further research.
Also, by tuning the design of the DNA hairpin, detection of
diverse molecular targets with high specificity, combined with
a simple experimental workflow, is possible.
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